Baxter EBITDA Margin 2010-2025 | BAX

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Baxter (BAX) over the last 10 years. The current EBITDA margin for Baxter as of March 31, 2025 is .
Baxter EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $10.77B $1.41B 13.04%
2024-12-31 $10.64B $1.49B 13.97%
2024-09-30 $9.54B $1.51B 15.82%
2024-06-30 $9.44B $1.93B 20.41%
2024-03-31 $9.34B $1.64B 17.51%
2023-12-31 $10.36B $1.69B 16.32%
2023-09-30 $8.97B $0.68B 7.54%
2023-06-30 $9.98B $0.97B 9.75%
2023-03-31 $9.86B $1.28B 13.00%
2022-12-31 $10.06B $1.38B 13.75%
2022-09-30 $13.79B $1.96B 14.24%
2022-06-30 $13.40B $2.11B 15.77%
2022-03-31 $12.91B $2.15B 16.68%
2021-12-31 $12.15B $2.22B 18.25%
2021-09-30 $12.45B $2.59B 20.81%
2021-06-30 $12.20B $2.55B 20.91%
2021-03-31 $11.82B $2.46B 20.78%
2020-12-31 $11.67B $2.46B 21.04%
2020-09-30 $11.53B $2.58B 22.39%
2020-06-30 $11.41B $2.60B 22.80%
2020-03-31 $11.53B $2.63B 22.77%
2019-12-31 $11.36B $2.59B 22.81%
2019-09-30 $11.14B $2.42B 21.70%
2019-06-30 $11.05B $2.30B 20.82%
2019-03-31 $11.06B $2.31B 20.85%
2018-12-31 $11.10B $2.36B 21.22%
2018-09-30 $11.08B $2.26B 20.40%
2018-06-30 $11.02B $2.16B 19.62%
2018-03-31 $10.79B $2.12B 19.61%
2017-12-31 $10.58B $2.04B 19.26%
2017-09-30 $10.43B $2.07B 19.80%
2017-06-30 $10.28B $1.97B 19.18%
2017-03-31 $10.26B $1.72B 16.71%
2016-12-31 $10.16B $1.55B 15.20%
2016-09-30 $10.12B $1.39B 13.68%
2016-06-30 $10.05B $1.30B 12.97%
2016-03-31 $9.94B $1.31B 13.14%
2015-12-31 $9.97B $1.21B 12.12%
2015-09-30 $10.15B $1.26B 12.36%
2015-06-30 $10.38B $1.27B 12.21%
2015-03-31 $12.06B $1.90B 15.78%
2014-12-31 $13.50B $2.53B 18.75%
2014-09-30 $15.03B $2.75B 18.28%
2014-06-30 $16.03B $3.29B 20.51%
2014-03-31 $15.55B $3.39B 21.79%
2013-12-31 $15.15B $3.38B 22.30%
2013-09-30 $14.33B $3.47B 24.23%
2013-06-30 $14.09B $3.57B 25.30%
2013-03-31 $14.00B $3.51B 25.09%
2012-12-31 $13.94B $3.48B 24.99%
2012-09-30 $14.03B $3.57B 25.47%
2012-06-30 $14.03B $3.54B 25.21%
2012-03-31 $14.00B $3.58B 25.58%
2011-12-31 $13.89B $3.62B 26.03%
2011-09-30 $13.80B $3.53B 25.56%
2011-06-30 $13.54B $3.56B 26.27%
2011-03-31 $13.20B $3.43B 25.95%
2010-12-31 $12.84B $2.82B 21.97%
2010-09-30 $12.82B $3.02B 23.60%
2010-06-30 $12.74B $2.97B 23.30%
2010-03-31 $12.67B $3.00B 23.70%
2009-12-31 $12.56B $3.52B 27.98%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $15.842B $10.636B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.294B 27.81
Boston Scientific (BSX) United States $157.073B 39.32
Stryker (SYK) United States $146.485B 30.63
EssilorLuxottica (ESLOY) France $131.510B 0.00
Medtronic (MDT) Ireland $104.117B 14.76
Haleon (HLN) United Kingdom $50.587B 28.80
Lonza Group Ag (LZAGY) Switzerland $49.544B 0.00
ResMed (RMD) United States $36.103B 27.12
GE HealthCare Technologies (GEHC) United States $32.514B 15.44
Agilent Technologies (A) United States $31.721B 20.95
Terumo (TRUMY) Japan $28.131B 36.54
Insulet (PODD) United States $22.987B 90.23
Koninklijke Philips (PHG) Netherlands $21.694B 15.60
Zimmer Biomet Holdings (ZBH) United States $18.639B 11.97
Smith & Nephew SNATS (SNN) United Kingdom $12.666B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.269B 21.81
Lantheus Holdings (LNTH) United States $5.242B 13.22
Prestige Consumer Healthcare (PBH) United States $4.244B 18.96
Perrigo (PRGO) Ireland $3.757B 9.52
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.266B 14.88
ICU Medical (ICUI) United States $3.210B 23.67
Envista Holdings (NVST) United States $3.051B 25.35
GN Store Nord (GNNDY) Denmark $2.163B 17.92
QuidelOrtho (QDEL) United States $2.114B 14.54
LeMaitre Vascular (LMAT) United States $1.868B 41.76
AtriCure (ATRC) United States $1.683B 0.00
Neogen (NEOG) United States $1.335B 17.08
Acuren (TIC) United States $1.317B 0.00
AdaptHealth (AHCO) United States $1.256B 12.75
Kestra Medical Technologies (KMTS) United States $1.156B 0.00
Green Thumb Industries (GTBIF) United States $1.120B 25.19
BioLife Solutions (BLFS) United States $1.057B 0.00
Phibro Animal Health (PAHC) United States $0.991B 12.67
InMode (INMD) Israel $0.919B 9.26
Evolus (EOLS) United States $0.633B 0.00
CeriBell (CBLL) United States $0.625B 0.00
Curaleaf Holdings (CURLF) Canada $0.590B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.568B 0.00
Valneva SE (VALN) France $0.534B 0.00
Owens & Minor (OMI) United States $0.509B 4.22
Capricor Therapeutics (CAPR) United States $0.479B 0.00
Tilray Brands (TLRY) Canada $0.446B 0.00
Surmodics (SRDX) United States $0.412B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.339B 0.00
Cresco Labs (CRLBF) United States $0.324B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.86
Canopy Growth (CGC) Canada $0.313B 0.00
Aurora Cannabis (ACB) Canada $0.307B 54.70
Sanara MedTech (SMTI) United States $0.274B 0.00
Viemed Healthcare (VMD) United States $0.261B 22.00
ZimVie (ZIMV) United States $0.245B 11.11
Cerus (CERS) United States $0.241B 0.00
Sanuwave Health (SNWV) United States $0.239B 0.00
Verano Holdings (VRNOF) United States $0.237B 0.00
Biote (BTMD) United States $0.223B 6.28
TriSalus Life Sciences (TLSI) United States $0.212B 0.00
OraSure Technologies (OSUR) United States $0.207B 0.00
Brainsway (BWAY) Israel $0.201B 53.25
Quanterix (QTRX) United States $0.197B 0.00
Omeros (OMER) United States $0.186B 0.00
High Tide (HITI) Canada $0.185B 0.00
Organigram Global (OGI) Canada $0.179B 0.00
Utah Medical Products (UTMD) United States $0.178B 14.46
Exagen (XGN) United States $0.145B 0.00
FitLife Brands (FTLF) United States $0.136B 16.69
Jin Medical (ZJYL) China $0.124B 0.00
TerrAscend (TSNDF) Canada $0.114B 0.00
MacroGenics (MGNX) United States $0.094B 0.00
Agape ATP (ATPC) $0.092B 0.00
Fonar (FONR) United States $0.089B 11.42
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Zynex (ZYXI) United States $0.078B 0.00
Quipt Home Medical (QIPT) United States $0.076B 0.00
Veru (VERU) United States $0.075B 0.00
InterCure (INCR) Israel $0.071B 0.00
Apyx Medical (APYX) United States $0.067B 0.00
Jushi Holdings (JUSHF) United States $0.060B 0.00
ImmuCell (ICCC) United States $0.056B 0.00
United Health Products (UEEC) United States $0.052B 0.00
Cytosorbents (CTSO) United States $0.051B 0.00
Modular Medical (MODD) United States $0.047B 0.00
United-Guardian (UG) United States $0.039B 13.47
Rockwell Medical (RMTI) United States $0.033B 0.00
Nephros (NEPH) United States $0.031B 41.86
Safety Shot (SHOT) United States $0.029B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Senestech (SNES) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00